Literature DB >> 21163830

Emergence of OXA-carbapenemase- and 16S rRNA methylase-producing international clones of Acinetobacter baumannii in Norway.

Nabil Karah1,2, Bjørg Haldorsen2, Nils O Hermansen3, Yngvar Tveten4, Eivind Ragnhildstveit5, Dag H Skutlaberg6, Ståle Tofteland7, Arnfinn Sundsfjord1,2, Ørjan Samuelsen2.   

Abstract

This study was designed to investigate the molecular epidemiology and antibiotic-resistance characteristics of 11 carbapenem-resistant clinical isolates of Acinetobacter baumannii obtained in Norway between 2004 and 2009. Interestingly, all the isolates were linked with recent hospitalization outside Norway. The epidemiological status was investigated by multilocus sequence typing (MLST), multiplex PCR assays for major international clones, typing of blaOXA-51-like variants and PFGE. The genotypic-resistance characteristics, including the occurrence of OXA-carbapenemase-encoding and 16S rRNA methylase-encoding genes and class 1 integrons, were investigated by PCR assays and sequencing. Seven isolates were found to harbour blaOXA-66 and belong to MLST clonal complexes (CCs) CC2P (Pasteur Institute scheme) and CC92B (Bartual scheme), and international clone II. One isolate harboured blaOXA-69, and belonged to CC1P, CC109B and international clone I. Two isolates belonged to sequence group 9, probably a subgroup of international clone I, and one isolate belonged to sequence group 4, a proposed novel international clone. All isolates contained an acquired OXA-carbapenemase-encoding gene: blaOXA-23-like (n=9), blaOXA-24-like (n=1) and blaOXA-58-like (n=1). Four isolates with high-level aminoglycoside-resistance contained the 16S rRNA methylase-encoding armA gene. Class 1 integrons with six different variable regions were detected. Sequence analysis of gene cassettes identified four aminoglycoside (aacA4, aac(6')-Im, aadA1 and aacC1), two chloramphenicol (catB8 and cm1A5), one β-lactamase (blaOXA-20) and one rifampicin (arr-2) resistance gene in various combinations. In conclusion, the occurrence of A. baumannii isolates producing OXA carbapenemase and 16S rRNA methylase in Norway was related to the worldwide distribution of international clones I and II, and the emergence of novel international clones.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21163830     DOI: 10.1099/jmm.0.028340-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  25 in total

1.  Emergence of Acinetobacter baumannii international clone II in Brazil: reflection of a global expansion.

Authors:  Natacha Martins; Libera Dalla-Costa; Aline Almeida Uehara; Lee Woodland Riley; Beatriz Meurer Moreira
Journal:  Infect Genet Evol       Date:  2013-10-10       Impact factor: 3.342

2.  Dissemination of a carbapenem-resistant Acinetobacter baumannii strain belonging to international clone II/sequence type 2 and harboring a novel AbaR4-like resistance island in Latvia.

Authors:  Mara Saule; Ørjan Samuelsen; Uga Dumpis; Arnfinn Sundsfjord; Aija Karlsone; Arta Balode; Edvins Miklasevics; Nabil Karah
Journal:  Antimicrob Agents Chemother       Date:  2012-12-10       Impact factor: 5.191

Review 3.  Epidemiological aspects of healthcare-associated infections and microbial genomics.

Authors:  C Mirande; I Bizine; A Giannetti; N Picot; A van Belkum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-17       Impact factor: 3.267

4.  Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives.

Authors:  Sylvie Garneau-Tsodikova; Kristin J Labby
Journal:  Medchemcomm       Date:  2015-09-21       Impact factor: 3.597

5.  Novel variants of AbaR resistance islands with a common backbone in Acinetobacter baumannii isolates of European clone II.

Authors:  Vaida Seputiene; Justas Povilonis; Edita Suziedeliene
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

6.  Comparison of molecular typing methods for the analyses of Acinetobacter baumannii from ICU patients.

Authors:  J Kristie Johnson; Gwen L Robinson; LiCheng Zhao; Anthony D Harris; O Colin Stine; Kerri A Thom
Journal:  Diagn Microbiol Infect Dis       Date:  2016-08-27       Impact factor: 2.803

7.  Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit.

Authors:  Keyvan Razazi; Lennie P G Derde; Marine Verachten; Patrick Legrand; Philippe Lesprit; Christian Brun-Buisson
Journal:  Intensive Care Med       Date:  2012-08-15       Impact factor: 17.440

8.  First detection of OXA-24 carbapenemase-producing Acinetobacter baumannii isolates in Bulgaria.

Authors:  Bozhana Todorova; Tzvetan Velinov; Ivan Ivanov; Elina Dobreva; Todor Kantardjiev
Journal:  World J Microbiol Biotechnol       Date:  2013-11-28       Impact factor: 3.312

9.  Clonal spread of carbapenem resistant Acinetobacter baumannii ST92 in a Chinese Hospital during a 6-year period.

Authors:  Lei Huang; Liying Sun; Yan Yan
Journal:  J Microbiol       Date:  2013-03-02       Impact factor: 3.422

Review 10.  OXA β-lactamases.

Authors:  Benjamin A Evans; Sebastian G B Amyes
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.